← Leaderboards
Benjamin J Burwitz
Oregon Health & Science University
$8,362,920
Attributed
$9,495,524
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2018–25$2.5M$1.9M$1.3M$625K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,495,524 · 5
By mechanism
R01$8,541,025 · 3
R21$954,499 · 2
Top collaborators
- Benjamin Bimber2 shared
- Jamie Lo1 shared
- Jennifer Manuzak1 shared
Most similar at Oregon Health & Science University
Same institution · by research overlap
- Elinor L. Sullivan$13,925,205
- Jamie Lo$4,653,881
- Joel T Nigg$26,089,587
- Oleg Varlamov$3,759,554
- Lisa M Coussens$10,998,130
Others in their field
Other Emerging Leaders on “Macaca Mulatta”
- Julie Ake · National Institute Of Allergy And Infectious Diseases$22,000,000
- Greg Westergaard · Alpha Genesis Inc$15,926,640
- Sandhya Vasan · Henry M. Jackson Fdn For The Adv Mil/Med$12,579,390
- Francois Villinger · University Of Louisiana At Lafayette$12,577,851
- Jacob D Estes · Oregon Health & Science University$12,010,074
- Deanna A Kulpa · Emory University$8,444,989
Research focus
Macaca MulattaCellsAnimalsVectorInfectionFrequenciesLiverHepatitis B VirusChronic Hepatitis BGlobal HealthSamplingHepatocyteDesignT Cell ResponseCd8-Positive T-LymphocytesT-LymphocyteAdultExhaustionPrimatesTissuesGenomicsMacacaEnsureIn Vitro
Grant awards (15)
Impact of Chronic Prenatal THC Exposure on SIV-associated Inflammation and Impairments in Placental and Fetal Development$1,336,938
R01 · FY2025 · DA
A Rhesus Macaque Model of HIV and HBV co-infection$732,070
R01 · FY2025 · AI · contact PI
Rapid Generation of Transgenic Rhesus Macaques using a Safe-harbor Genomic Docking Site$219,375
R21 · FY2025 · OD
A Rhesus Macaque Model of HIV and HBV co-infection$782,991
R01 · FY2024 · AI · contact PI
Rapid Generation of Transgenic Rhesus Macaques using a Safe-harbor Genomic Docking Site$263,250
R21 · FY2024 · OD
A Rhesus Macaque Model of HIV and HBV co-infection$762,977
R01 · FY2023 · AI · contact PI
Adoptive MHC-E-Restricted T Cell Therapy for the Treatment of Chronic Hepatitis B Virus Infection$673,614
R01 · FY2023 · AI · contact PI
A Rhesus Macaque Model of HIV and HBV co-infection$775,817
R01 · FY2022 · AI · contact PI
Adoptive MHC-E-Restricted T Cell Therapy for the Treatment of Chronic Hepatitis B Virus Infection$571,249
R01 · FY2022 · AI · contact PI
A Rhesus Macaque Model of HIV and HBV co-infection$789,125
R01 · FY2021 · AI · contact PI
Adoptive MHC-E-Restricted T Cell Therapy for the Treatment of Chronic Hepatitis B Virus Infection$737,535
R01 · FY2021 · AI · contact PI
Adoptive MHC-E-Restricted T Cell Therapy for the Treatment of Chronic Hepatitis B Virus Infection$715,124
R01 · FY2020 · AI · contact PI
Adoptive MHC-E-Restricted T Cell Therapy for the Treatment of Chronic Hepatitis B Virus Infection$663,585
R01 · FY2019 · AI · contact PI
Creation of a chronic HBV infection model in rhesus macaques$253,124
R21 · FY2019 · AI · contact PI
Creation of a chronic HBV infection model in rhesus macaques$218,750
R21 · FY2018 · AI · contact PI